Triple‐negative breast cancer (TNBC), which lacks oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), accounts for approximately 20% of all breast cancers [1]. This evidence concerns the gene ERBB2 and breast carcinoma.